These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 138094)

  • 21. Pharmacologic modulation of acute uveitis with aminonicotinamide.
    Marak GE; Sery TW; Gregerson D; Donoso LA; Rao NA
    Ophthalmic Res; 1990; 22(2):111-6. PubMed ID: 2140443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of hexose monophosphate shunt inhibitors on adenohypophyseal and ceruloplasmin reactions to oestrogen.
    Schreiber V; Pribyl T
    Physiol Bohemoslov; 1978; 27(4):301-7. PubMed ID: 151286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased GABA and glutamate concentration in rat brain after treatment with 6-aminonicotinamide.
    Bielicki L; Krieglstein J
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Aug; 294(2):157-60. PubMed ID: 138093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitation of metabolic and radiobiological effects of 6-aminonicotinamide in RIF-1 tumor cells in vitro.
    Street JC; Alfieri AA; Koutcher JA
    Cancer Res; 1997 Sep; 57(18):3956-62. PubMed ID: 9307279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Will inhibition of the hexose monophosphate shunt increase resistance to oxygen deficiency?].
    Trojan S
    Sb Lek; 1987; 89(11-12):330-4. PubMed ID: 2965406
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of 6-aminonicotinamide on the levels of brain amino acids and glucose, and their labeling with 14C after injection of [U-14C] glucose.
    Gaitonde MK; Lewis LP; Evans G; Clapp A
    Neurochem Res; 1981 Oct; 6(10):1159-67. PubMed ID: 6121299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Repression of glial RNA transcription during the development of 6-aminonic-otinamide (6-AN)-induced acute gliopathy.
    Sarkander HI; Knoll-Köhler E; Cervos-Navarro J
    J Pharmacol Exp Ther; 1978 May; 205(2):503-14. PubMed ID: 147938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monitoring flux through the oxidative pentose phosphate pathway using [1-14C]gluconate.
    Garlick AP; Moore C; Kruger NJ
    Planta; 2002 Dec; 216(2):265-72. PubMed ID: 12447540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Normal and 6-aminonicotinamide impaired development of capillarization in occipital cortex of rat.
    Rauchfuss A
    Anat Embryol (Berl); 1978 Jul; 154(1):27-37. PubMed ID: 150239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ultrastructure of 6-aminonicotinamide (6-an)--induced lesions in the central nervous system of rats.
    Horita N; Oyanagi S; Ishii T; Izumiyama Y
    Acta Neuropathol; 1978 Nov; 44(2):111-9. PubMed ID: 152558
    [No Abstract]   [Full Text] [Related]  

  • 31. Glucose utilization in the central nervous system in the acute gliopathy due to 6-aminonicotinamide.
    Griffiths IR; Kelly PA; Grome JJ
    Lab Invest; 1981 Jun; 44(6):547-52. PubMed ID: 6453252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brain edema and gliopathy induced by 6-aminonicotinamide intoxication in the central nervous system of rats.
    Sasaki S
    Am J Vet Res; 1982 Sep; 43(9):1691-5. PubMed ID: 6216837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Studies on the effect of 6-aminonicotinamide on the glucose metabolism of fat tissue].
    von Bruchhausen F; Ofori-Nkansah N
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):223. PubMed ID: 4242376
    [No Abstract]   [Full Text] [Related]  

  • 34. 13C and 31P NMR investigation of effect of 6-aminonicotinamide on metabolism of RIF-1 tumor cells in vitro.
    Street JC; Mahmood U; Ballon D; Alfieri AA; Koutcher JA
    J Biol Chem; 1996 Feb; 271(8):4113-9. PubMed ID: 8626749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Age-dependent susceptibility of CNS glial populations in situ to the antimetabolite 6-aminonicotinamide.
    Krum JM
    Mol Chem Neuropathol; 1995 Oct; 26(2):79-94. PubMed ID: 8573244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of 6-aminonicotinamide on cell growth, poly(ADP-ribose) synthesis and nucleotide metabolism.
    Hunting D; Gowans B; Henderson JF
    Biochem Pharmacol; 1985 Nov; 34(22):3999-4003. PubMed ID: 2933043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolism of various carbon sources by Azospirillum brasilense.
    Westby CA; Cutshall DS; Vigil GV
    J Bacteriol; 1983 Dec; 156(3):1369-72. PubMed ID: 6417113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycolytic flux is conditionally correlated with ATP concentration in Saccharomyces cerevisiae: a chemostat study under carbon- or nitrogen-limiting conditions.
    Larsson C; Nilsson A; Blomberg A; Gustafsson L
    J Bacteriol; 1997 Dec; 179(23):7243-50. PubMed ID: 9393686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of increased glucose supply and thiopental anesthesia on energy metabolism of the isolated perfused rat brain.
    Hein H; Krieglstein J; Stock R
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 289(4):399-407. PubMed ID: 1161060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of gamma-aminobutyric acid transaminase with 6-aminonicotinamide in regions of the rat brain.
    Prakash MR; Baouer NZ
    Biochem Pharmacol; 1981 Mar; 30(6):663-4. PubMed ID: 6456007
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.